Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344.
Cancers (Basel)
; 15(3)2023 Jan 18.
Article
in En
| MEDLINE
| ID: mdl-36765955
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Cancers (Basel)
Year:
2023
Type:
Article
Affiliation country:
China